Socioeconomic costs of liver disease in Korea
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background/Aims: This study analyzed the scale and trends of the social and economic costs of liver disease in Korea for the past 5 years. Methods: The social aspects of socioeconomic costs were projected for viral hepatitis (B15-B19), liver cirrhosis, malignant neoplasm of the liver (C22) and other liver diseases (K70-K76), as representative diseases by dividing costs into direct and indirect from 2004 to 2008. Direct costs include hospitalization, outpatient, and pharmacy costs in the health-care sector, and transportation and caregiver costs. Indirect costs include the future income loss due to premature death and the loss of productivity resulting from absence from work. Results: The social and economic costs of liver disease were projected to be KRW 5,858 billion in 2004, KRW 5,572 billion in 2005, KRW 8,104 billion in 2006,KRW 6,095 billion in 2007, and KRW 5,689 billion in 2008. The future income loss resulting from premature death is thus greatest, from 73.9% to 86.1%, followed by the direct medical costs, from 9.0% to 18.1%. The productivity loss resulting from absence from work accounts for 3.3-5.5%, followed by the direct nonmedical costs such as transportation and caregiver costs, at 1.5-2.5%. Conclusions: Among the socioeconomic costs of liver disease in Korea, the future income loss resulting from premature death is showing a decreasing trend, whereas direct medical costs are increasing dramatically.
Abstract
Background/Aims: This study analyzed the scale and trends of the social and economic costs of liver disease in Korea for the past 5 years. Methods: The social aspects of socioeconomic costs were projected for viral hepatitis (B15-B19), liver cirrhosis, malignant neoplasm of the liver (C22) and other liver diseases (K70-K76), as representative diseases by dividing costs into direct and indirect from 2004 to 2008. Direct costs include hospitalization, outpatient, and pharmacy costs in the health-care sector, and transportation and caregiver costs. Indirect costs include the future income loss due to premature death and the loss of productivity resulting from absence from work. Results: The social and economic costs of liver disease were projected to be KRW 5,858 billion in 2004, KRW 5,572 billion in 2005, KRW 8,104 billion in 2006,KRW 6,095 billion in 2007, and KRW 5,689 billion in 2008. The future income loss resulting from premature death is thus greatest, from 73.9% to 86.1%, followed by the direct medical costs, from 9.0% to 18.1%. The productivity loss resulting from absence from work accounts for 3.3-5.5%, followed by the direct nonmedical costs such as transportation and caregiver costs, at 1.5-2.5%. Conclusions: Among the socioeconomic costs of liver disease in Korea, the future income loss resulting from premature death is showing a decreasing trend, whereas direct medical costs are increasing dramatically.
참고문헌 (34)
- "Annual report on the cause of death statistics" (2010)[URL]
- Jung YH, "An estimation of economic costs of 5 major diseases", Health and Welfare Policy Forum, 79, pp.55~65 (2003)
- Kim DJ, "Problems faced by Korean patients with chronic liver disease and the role of the Korean Association for the Study of the Liver- emphases on social discrimination, insufficiency of reimbursement coverage, and deficiency of the welfare system", Korean J Hepatol, 14, pp.125~135 (2008)
- Ettaro L, "Cost-of-illness studies in diabetes mellitus", Pharmacoeconomics, 22, pp.149~164 (2004)
- Currie G, "Are cost of injury studies useful", Inj Prev, 6, pp.175~176 (2000)
- Rice DP, "Cost of illness studies: what is good about them", Inj Prev, 6, pp.177~179 (2000)
- "Economic cost of chronic disease in Canada 1995-2003"[URL]
- American Diabetes Association, "Economic costs of diabetes in the U.S. In 2007", Diabetes Care, 31, pp.596~615 (2008)
- Rehm J, "Alcohol-attributable mortality and potential years of life lost in Canada 2001: implications for prevention and policy", Addiction, 101, pp.373~384 (2006)
- John RM, "Economic cost of tobacco use in India, 2004", Tob Control, 18, pp.138~143 (2009)
- Park TK, "Study on the economic costs of smoking in Korea", Korean J Public Econ, 5, pp.167~195 (2000)
- Kim HJ, "Analysis of socioeconomic costs of smoking in Korea", Korean J Prev Med, 34, pp.183~190 (2001)
- Fenoglio P, "The social cost of alcohol, tobacco and illicit drugs in France, 1997", Eur Addict Res, 9, pp.18~28 (2003)
- Socioeconomic costs and policy issues of alcohol drinking, "Noh IC", Korea Institute for Health and Social Affairs, 80~ (1997)
- 정우진, "음주의 사회경제적 비용 추계", 예방의학회지, 39(1), pp.21~29 (2006), 대한예방의학회
- Kouris-Blazos A, "Health economics of weight management: evidence and cost", Asia Pac J Clin Nutr, 16(1), pp.329~338 (2007)
- Colagiuri S, "The cost of overweight and obesity in Australia", Med J Aust, 192, pp.260~264 (2010)
- 정백근, "한국인 성인 비만의 사회경제적 비용", 예방의학회지, 35(1), pp.1~12 (2002), 대한예방의학회
- Rice DP, "Estimating the cost-of-illness", Am J Public Health Nations Health, 57, pp.424~440 (1967)
- Koopmanschap MA, "Cost-of-illness studies. Useful for health policy", Pharmacoeconomics, 14, pp.143~148 (1998)
- Byford S, "Economic note: cost of illness studies", BMJ, 320, pp.1335~ (2000)
- Drummond MF, "Methods for the economic evaluation of health care programmes. 3rd ed", pp.55~56 (2005), Oxford University Press
- 김진희, "2005년 암의 경제적 비용부담 추계", 예방의학회지, 42(3), pp.190~198 (2009), 대한예방의학회
- 박춘선, "건강보험 청구자료를 이용한 우리나라 천식환자의 질병비용부담 추계", 예방의학회지, 39(5), pp.397~403 (2006), 대한예방의학회
- "National Health Insurance statistical yearbook. 2005-2009"[URL]
- "Survey on the benefit coverage rate of national health insurance in 2008"[URL]
- "Annual report on the consumer price index. 2005-2009"[URL]
- "A report of Korea health panel survey 2008 (1)"[URL]
- "Annual report on the cause of death statistics. 2005-2009"[URL]
- "Life tables for Korea. 2005-2009"[URL]
- "Annual report on the economically active population survey. 2005-2009"[URL]
- "Basic survey on wage structure. 2005-2009"[URL]
- "Survey report on the wages and working hours at establishments. 2004-2008"[URL]
- "Economic burden of illness in Canada" (1998)[URL]